Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Vijairam SelvarajSaurav ChatterjeeTaishi HiraiJ Dawn AbbottChirag P BavishiPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
In patients with ACS undergoing PCI, 3-month DAPT reduced risk of bleeding without evidence of harm.
Keyphrases
- antiplatelet therapy
- percutaneous coronary intervention
- acute coronary syndrome
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- atrial fibrillation
- systematic review
- coronary artery bypass
- heart failure
- left ventricular